Nature Podcast

by podcast@nature.com · · · · 211 subscribers

The Nature Podcast brings you the best stories from the world of science each week. We cover everything from astronomy to zoology, highlighting the most exciting research from each issue of the Nature journal. We meet the scientists behind the results and provide in-depth analysis from Nature 's journalists and editors.


Hosted on Acast. See acast.com/privacy for more information.

Delta has quickly become the dominant COVID variant in many countries across the world, in this episode we ask why. Over the past few weeks, a slew of studies have started to shed more light on how the Delta variant differs from its cousins and even th...
A team is creating bespoke words for scientific terms in African languages, and the sustainability of the electric car boom.
Several wealthy nations have announced plans to give third vaccine doses in a bid to help increase the protection of their most vulnerable citizens - but the science is not clear on whether this strategy will be effective or indeed necessary. Meanwhile...
Researchers uncover how grid cells fire in a 3D space to help bats navigate, and a fabric that switches between being stiff and flexible.
Ivermectin is a cheap, widely available, anti-parasitic drug that has been proposed by many as a possible treatment for COVID-19. Dozens of trials have been started, but results have been far from clear, with inconsistent results further confused by hi...
Satellite imaging has shown population increases are 10x higher in flood prone areas, and a new way to introduce fairness into a democratic process.
Researchers debate whether an ancient fossil is the oldest animal yet discovered, and a new way to eavesdrop on glaciers.
Archaeological evidence shows that ancient people ate bread, beer and other carbs, long before domesticated crops.
Early in 2021 the United Kingdom, along with several other countries, allowed mass gatherings as part of a series of controlled studies aimed at better understanding the role events could play in the pandemic. The goal was to inform policy - however ea...
Funding for gun violence research in the US returns after a 20-year federal hiatus, and the glass sponges that can manipulate ocean currents.
The UK government has announced that virtually all COVID restrictions will be removed in England on Monday 18th July. This will do away with social distancing requirements, allow businesses to re-open to full capacity and remove legal mask mandates. Th...
Heat waves have disproportionate impacts on minorities in US cities, and after critiquing his own papers a researcher extols the value of self-criticism.
For much of the pandemic, the greatest burden of disease has been felt by older generations. But now, for the first time, vaccine roll outs are starting to skew the average age of those infections towards the young. This has led many researchers to ask...
Addressing the problem of sudden food scarcity in US cities, and the up-and- coming field of computational social science.
Since the beginning oft he pandemic, researchers have searched for a biomarker which indicates immune protection from COVID-19 known as a correlate of protection. Now, the team developing the Oxford–AstraZeneca COVID-19 vaccine have published the first...
A historian reflects on the life of Chinese crop scientist Yuan Longping, and the possible influence of geothermal energy production on earthquake aftershocks.
This is an audio version of our feature: How COVID broke the evidence pipeline
Early vaccine trials did not include pregnant or breastfeeding people which left some people asking whether COVID vaccines are safe and effective for those who are breastfeeding. The latest data suggests that they are and in this episode of Co...
Researchers isolate the protein thought to allow birds to sense magnetic fields, and astronomers pinpoint the stars that could view Earth as an exoplanet.
After a slew of wildly successful vaccine trials, this week marked a more underwhelming result. The third mRNA vaccine to complete phase three trials, developed by CureVac, is just 47% effective at staving off disease according to preliminary data. Thi...